Brian A Dukek
Overview
Explore the profile of Brian A Dukek including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
222
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Baig N, Dukek B, Falbo D, Wakefield L, DiGuardo M, Bobr A, et al.
Vox Sang
. 2020 Aug;
116(1):116-122.
PMID: 32797679
Background: Daratumumab (DARA), a human IgG1 monoclonal antibody targeting CD38, is used to treat refractory multiple myeloma patients. CD38 is expressed on many cell types (RBCs, granulocytes, lymphocytes, etc.), and...
2.
Majumder S, Raimondo M, Taylor W, Yab T, Berger C, Dukek B, et al.
Clin Gastroenterol Hepatol
. 2019 Jul;
18(3):676-683.e3.
PMID: 31323382
Background & Aims: Precursors of pancreatic cancer arise in the ductal epithelium; markers exfoliated into pancreatic juice might be used to detect high-grade dysplasia (HGD) and cancer. Specific methylated DNA...
3.
Majumder S, Taylor W, Yab T, Berger C, Dukek B, Cao X, et al.
Am J Gastroenterol
. 2019 Jul;
114(9):1539-1549.
PMID: 31306149
Objectives: Pancreatic cystic lesions (PCLs) may be precancerous. Those likely to harbor high-grade dysplasia (HGD) or pancreatic cancer (PC) are targets for surgical resection. Current algorithms to predict advanced neoplasia...
4.
Dukek B, Zuccarelli M, Wakefield L, Kreuter J, Gandhi M
HLA
. 2018 Nov;
93(1):49-50.
PMID: 30421561
Discovery of a novel HLA-B*45:22 allele in a Middle Eastern heart and lung transplant candidate.
5.
Kisiel J, Dukek B, V S R Kanipakam R, Ghoz H, Yab T, Berger C, et al.
Hepatology
. 2018 Sep;
69(3):1180-1192.
PMID: 30168613
Early detection improves hepatocellular carcinoma (HCC) outcomes, but better noninvasive surveillance tools are needed. We aimed to identify and validate methylated DNA markers (MDMs) for HCC detection. Reduced representation bisulfite...
6.
Anderson B, Suh Y, Choi B, Lee H, Yab T, Taylor W, et al.
Clin Cancer Res
. 2018 May;
24(22):5724-5734.
PMID: 29844130
Gastric adenocarcinoma is the third most common cause of cancer mortality worldwide. Accurate and affordable noninvasive detection methods have potential value for screening and surveillance. Herein, we identify novel methylated...
7.
Wu C, Evans J, Huang S, Mahoney D, Dukek B, Taylor W, et al.
BMC Genomics
. 2018 May;
19(1):401.
PMID: 29801434
Background: MicroRNA (miRNA) profiling is an important step in studying biological associations and identifying marker candidates. miRNA exists in isoforms, called isomiRs, which may exhibit distinct properties. With conventional profiling...
8.
Kramer W, Walker D, OKane D, Mrazek D, Fisher P, Dukek B, et al.
Pharmacogenet Genomics
. 2009 Sep;
19(10):813-22.
PMID: 19741566
Objective: CYP2D6 is a polymorphic gene. It has been observed to be deleted, to be duplicated and to undergo recombination events involving the CYP2D7 pseudogene and surrounding sequences. The objective...
9.
Titapiwatanakun R, Rodriguez V, Middha S, Dukek B, Pruthi R
Pediatr Blood Cancer
. 2009 Apr;
53(1):92-5.
PMID: 19340858
Congenital combined deficiency of the vitamin K-dependent coagulation factors is a rare bleeding disorder caused by either a defect in the gamma-glutamyl carboxylase or the vitamin K epoxide reductase enzyme...